Form 8-K - Current report:
SEC Accession No. 0001104659-24-079101
Filing Date
2024-07-11
Accepted
2024-07-11 08:00:31
Documents
16
Period of Report
2024-07-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2419264d1_8k.htm   iXBRL 8-K 45033
2 EXHIBIT 4.1 tm2419264d1_ex4-1.htm EX-4.1 102648
3 EXHIBIT 10.1 tm2419264d1_ex10-1.htm EX-10.1 55405
4 EXHIBIT 99.1 tm2419264d1_ex99-1.htm EX-99.1 11158
  Complete submission text file 0001104659-24-079101.txt   440410

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20240710.xsd EX-101.SCH 3027
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20240710_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20240710_pre.xml EX-101.PRE 22367
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2419264d1_8k_htm.xml XML 3685
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 241111057
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)